Eli Lilly wins China approval for weight-loss pill orforglipron
China weight-loss pill approval for Eli Lilly's orforglipron puts it ahead of Novo Nordisk, Pfizer and Innovent in the country's obesity market.
Markets
Delayed · 11:24 UK
Topic
Every Financial News story tagged GLP-1, newest first.
China weight-loss pill approval for Eli Lilly's orforglipron puts it ahead of Novo Nordisk, Pfizer and Innovent in the country's obesity market.